Clinical Trial Update: Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

View source ↗

Summary

A clinical trial is assessing whether immunoglobulin replacement can address fatigue in patients with Multiple Sclerosis who have hypogammaglobulinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogammaglobulinemia
• Multiple Sclerosis

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Hypogammaglobulinemia, Multiple Sclerosis | Status: RECRUITING